2 weeks Ago By ABMN Staff
Cardinal Health, Inc. ( NYSE:CAH – Free Report ) – Analysts at Leerink Partnrs lowered their Q1 2025 earnings per share (EPS) estimates for Cardinal Health in a research report issued to clients and investors on Thursday, August 29th. Leerink Partnrs analyst M.
Cherny now forecasts that the company will post earnings per share of $1.64 for the quarter, down from their previous forecast of $1.72.
The consensus estimate for Cardinal Health’s current full-year earnings is $7.35 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q3 2025 earnings at $2.
18 EPS. Cardinal Health ( NYSE:CAH – Get Free Report ) last announced its earnings results on Wednesday, August 14th. The company reported $1.
84 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.74 by $0.10.
Cardinal Health had a negative return on equity of 54.74% and a net margin of 0.25%.
The business had revenue of $59.87 billion for the quarter, compared to analyst estimates of $58.74 billion.
During the same period in the previous year, the company earned $1.55 earnings per share. The company’s revenue for the quarter was up 12.
1% compared to the same quarter last year. Check Out Our Latest Research Report on CAH Cardinal Health Stock Performance Shares of NYSE CAH opened at $112.72 on Friday.
The firm has a market cap of $27.45 billion, a price-to-earnings ratio of 50.10, a PEG ratio of 1.
14 and a beta of 0.61. Cardinal Health has a 1 year low of $85.
82 and a 1 year high of $116.04. The stock’s 50-day simple moving average is $101.
14 and its 200-day simple moving average is $103.61. Institutional Investors Weigh In On Cardinal Health Hedge funds and other institutional investors have recently added to or reduced their stakes in the company.
Mather Group LLC. increased its holdings in shares of Cardinal Health by 2.5% in the fourth quarter.
Mather Group LLC. now owns 6,678 shares of the company’s stock valued at $673,000 after buying an additional 164 shares in the last quarter. Cambridge Investment Research Advisors Inc.
increased its holdings in shares of Cardinal Health by 86.8% in the fourth quarter. Cambridge Investment Research Advisors Inc.
now owns 69,423 shares of the company’s stock valued at $6,998,000 after buying an additional 32,250 shares in the last quarter. Pinebridge Investments L.P.
increased its holdings in shares of Cardinal Health by 237.7% in the fourth quarter. Pinebridge Investments L.
P. now owns 171,530 shares of the company’s stock valued at $17,290,000 after buying an additional 120,740 shares in the last quarter. Tobam increased its holdings in shares of Cardinal Health by 773.
4% in the first quarter. Tobam now owns 49,111 shares of the company’s stock valued at $5,496,000 after buying an additional 43,488 shares in the last quarter. Finally, Nomura Holdings Inc.
raised its stake in Cardinal Health by 12.3% during the 4th quarter. Nomura Holdings Inc.
now owns 220,661 shares of the company’s stock valued at $22,243,000 after purchasing an additional 24,222 shares during the period. Institutional investors own 87.17% of the company’s stock.
Insider Transactions at Cardinal Health In other news, CEO Jason M. Hollar sold 26,716 shares of the business’s stock in a transaction that occurred on Friday, August 16th. The stock was sold at an average price of $108.
87, for a total transaction of $2,908,570.92. Following the completion of the transaction, the chief executive officer now directly owns 244,091 shares in the company, valued at $26,574,187.
17. The sale was disclosed in a legal filing with the SEC, which is accessible through this link . In related news, CFO Aaron E.
Alt sold 2,323 shares of the business’s stock in a transaction that occurred on Monday, August 19th. The stock was sold at an average price of $108.91, for a total transaction of $252,997.
93. Following the sale, the chief financial officer now owns 36,867 shares of the company’s stock, valued at $4,015,184.97.
The sale was disclosed in a filing with the SEC, which is available through the SEC website . Also, CEO Jason M. Hollar sold 26,716 shares of the business’s stock in a transaction that occurred on Friday, August 16th.
The stock was sold at an average price of $108.87, for a total value of $2,908,570.92.
Following the sale, the chief executive officer now directly owns 244,091 shares in the company, valued at approximately $26,574,187.17. The disclosure for this sale can be found here .
Over the last three months, insiders sold 113,963 shares of company stock worth $12,379,980. Company insiders own 0.15% of the company’s stock.
Cardinal Health Increases Dividend The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Tuesday, October 1st will be given a dividend of $0.506 per share.
The ex-dividend date of this dividend is Tuesday, October 1st. This is an increase from Cardinal Health’s previous quarterly dividend of $0.51.
This represents a $2.02 annualized dividend and a dividend yield of 1.80%.
Cardinal Health’s payout ratio is currently 89.78%. Cardinal Health Company Profile ( Get Free Report ) Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally.
It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. Read More Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter .
.
